Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Glaus

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioconjugate Chemistry|April 1, 2010
In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agentCharles Glaus, Raffaella Rossin, Michael J Welch, et al.
Trends in Molecular Medicine|November 16, 2010
Inorganic nanoparticle-based contrast agents for molecular imagingEun Chul Cho, Charles Glaus, Jingyi Chen, et al.
International Journal of Biomedical Imaging|October 1, 2021
Automatic Quantification of Atherosclerosis in Contrast-Enhanced MicroCT Scans of Mouse Aortas Ex VivoVincent A Stadelmann, Gabrielle Boyd, Martin Guillot, et al.
Nuclear Medicine and Biology|March 5, 2013
Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft modelKaren Rex, Xiaoman Z Lewis, Sundaresan Gobalakrishnan, et al.
NPJ Vaccines|December 10, 2020
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responsesCarlos A Arbelaez, Juan Estrada, Melissa A Gessner, et al.
Advanced Functional Materials|April 28, 2021
Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic ApplicationsJingyi Chen, Miaoxin Yang, Qiang Zhang, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 26, 2013
Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal modelMatthew D Silva, Charles Glaus, Jacob Y Hesterman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of <sup>225</sup>Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular CarcinomaJorrit Tjeertes, Miroslav Dostalek, Charles Glaus, et al.
Molecular Therapy. Methods & Clinical Development|June 26, 2023
Gene therapy for cross-correction of somatic organs and the CNS in mucopolysaccharidosis II in rodents and non-human primatesNancy Chen, David E Ehmann, Robert Crooker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2017
Local Delivery of OncoVEX<sup>mGM-CSF</sup> Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein BlockadeAchim K Moesta, Keegan Cooke, Julia Piasecki, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|April 1, 2010
In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agentCharles Glaus, Raffaella Rossin, Michael J Welch, et al.
Trends in Molecular Medicine|November 16, 2010
Inorganic nanoparticle-based contrast agents for molecular imagingEun Chul Cho, Charles Glaus, Jingyi Chen, et al.
International Journal of Biomedical Imaging|October 1, 2021
Automatic Quantification of Atherosclerosis in Contrast-Enhanced MicroCT Scans of Mouse Aortas Ex VivoVincent A Stadelmann, Gabrielle Boyd, Martin Guillot, et al.
Nuclear Medicine and Biology|March 5, 2013
Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft modelKaren Rex, Xiaoman Z Lewis, Sundaresan Gobalakrishnan, et al.
NPJ Vaccines|December 10, 2020
A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responsesCarlos A Arbelaez, Juan Estrada, Melissa A Gessner, et al.
Advanced Functional Materials|April 28, 2021
Gold Nanocages: A Novel Class of Multifunctional Nanomaterials for Theranostic ApplicationsJingyi Chen, Miaoxin Yang, Qiang Zhang, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 26, 2013
Regional, kinetic [(18)F]FDG PET imaging of a unilateral Parkinsonian animal modelMatthew D Silva, Charles Glaus, Jacob Y Hesterman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of <sup>225</sup>Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular CarcinomaJorrit Tjeertes, Miroslav Dostalek, Charles Glaus, et al.
Molecular Therapy. Methods & Clinical Development|June 26, 2023
Gene therapy for cross-correction of somatic organs and the CNS in mucopolysaccharidosis II in rodents and non-human primatesNancy Chen, David E Ehmann, Robert Crooker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2017
Local Delivery of OncoVEX<sup>mGM-CSF</sup> Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein BlockadeAchim K Moesta, Keegan Cooke, Julia Piasecki, et al.
Pageof 2